Explore more publications!
The Middle East Health Journal
Got News to Share?

The Middle East Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

Press releases published on January 12, 2026

Press Release Biocartis NV: Biocartis to collaborate with Mayo Clinic on breast cancer gene signatures
Jan. 12, 2026

Press Release Biocartis NV: Biocartis to collaborate with Mayo Clinic on breast cancer gene signatures

Indeterminate GlobeNewswire
Acentra Health Honored as One of Modern Healthcare’s 2025 Best in Business
Jan. 12, 2026

Acentra Health Honored as One of Modern Healthcare’s 2025 Best in Business

Indeterminate GlobeNewswire
Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference
Jan. 12, 2026

Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases
Jan. 12, 2026

PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases

Indeterminate GlobeNewswire
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Spear Bio for the Transformative Bio-Hermes-002 Study
Jan. 12, 2026

Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Spear Bio for the Transformative Bio-Hermes-002 Study

Indeterminate GlobeNewswire
PacBio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue
Jan. 12, 2026

PacBio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue

Indeterminate GlobeNewswire
InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC)
Jan. 12, 2026

InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC)

Indeterminate GlobeNewswire
Helsinn announces new Executive Leadership Team as it celebrates 50 years
Jan. 12, 2026

Helsinn announces new Executive Leadership Team as it celebrates 50 years

Indeterminate GlobeNewswire
AOP Health’s Rapiblyk™ Now Accessible via Leading US Healthcare Improvement Companies
Jan. 12, 2026

AOP Health’s Rapiblyk™ Now Accessible via Leading US Healthcare Improvement Companies

Indeterminate GlobeNewswire
VIVUS Shares Progress on Pipeline and Key Program Milestones During the 44th Annual J.P. Morgan Healthcare Conference
Jan. 12, 2026

VIVUS Shares Progress on Pipeline and Key Program Milestones During the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics
Jan. 12, 2026

Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics

Indeterminate GlobeNewswire
Oncolytics Biotech® Announces Updated Clinical Data from GOBLET Cohort 4 Demonstrating Activity of Pelareorep Plus Atezolizumab in Third-Line Anal Cancer
Jan. 12, 2026

Oncolytics Biotech® Announces Updated Clinical Data from GOBLET Cohort 4 Demonstrating Activity of Pelareorep Plus Atezolizumab in Third-Line Anal Cancer

Indeterminate GlobeNewswire
Dentsply Sirona Appoints Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization
Jan. 12, 2026

Dentsply Sirona Appoints Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization

Indeterminate GlobeNewswire
Tevogen Demonstrates Platform Scalability and Multi-Indication T Cell Pipeline Expansion in 2025
Jan. 12, 2026

Tevogen Demonstrates Platform Scalability and Multi-Indication T Cell Pipeline Expansion in 2025

Indeterminate GlobeNewswire
PainReform’s LayerBio’s Drop-Less OcuRing™-K Delivery Platform Demonstrates Favorable Safety Profile in Preclinical and Phase I Clinical Studies
Jan. 12, 2026

PainReform’s LayerBio’s Drop-Less OcuRing™-K Delivery Platform Demonstrates Favorable Safety Profile in Preclinical and Phase I Clinical Studies

Indeterminate GlobeNewswire
ZYUS Life Sciences Announces LIFE Offering of a minimum of C$15 Million and maximum of C$16 Million of Units
Jan. 12, 2026

ZYUS Life Sciences Announces LIFE Offering of a minimum of C$15 Million and maximum of C$16 Million of Units

Indeterminate GlobeNewswire
HealthEquity Announces Fiscal Year 2027 Outlook Presentation at J.P. Morgan Healthcare Conference
Jan. 12, 2026

HealthEquity Announces Fiscal Year 2027 Outlook Presentation at J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer
Jan. 12, 2026

Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer

Indeterminate GlobeNewswire
Actuate Therapeutics Reports Positive Follow-Up Data from its Randomized Controlled Phase 2 Trial Demonstrating Extended Long-Term Overall Survival Benefit with Elraglusib Plus Chemotherapy for Metastatic Pancreatic Cancer in Oral Presentation at ASCO…
Jan. 12, 2026

Actuate Therapeutics Reports Positive Follow-Up Data from its Randomized Controlled Phase 2 Trial Demonstrating Extended Long-Term Overall Survival Benefit with Elraglusib Plus Chemotherapy for Metastatic Pancreatic Cancer in Oral Presentation at ASCO…

Indeterminate GlobeNewswire
CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2026 Milestones
Jan. 12, 2026

CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2026 Milestones

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions